Alfred Wittinghofer
Alfred Wittinghofer is a biochemist at the Max Planck Institute for Molecular Physiology in Dortmund, Germany. He is renowned for his pioneering work on the structure of RAS proteins, which has laid the foundation for the development of targeted cancer therapies, including the recently introduced Daraxonrasib.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Alfred Wittinghofer is a biochemist at the Max Planck Institute for Molecular Physiology who elucidated the structure of various RAS proteins in the 1980s and 1990s.
7